CALL US:022-6101 1710   sales@saffronmedia.in
HOME NEWS INGREDIENT MART EVENTS TOPICS INTERVIEW EDIT
 
News
 
Shardul Nautiyal, Mumbai November 20 , 2026
The Indian pharmaceutical industry needs to move beyond conventional regulatory compliance and periodic employee training to establish an integrated framework of quality culture and continuous skill enhancement, as manufacturers prepare to meet the changing requirements of global regulated markets, advanced therapeutics and digital manufacturing.

The transition from being a global supplier of affordable generic medicines to an emerging centre for pharmaceutical innovation requires companies to strengthen two interconnected capabilities: embedding quality into organisational behaviour and developing a workforce equipped to manage evolving scientific, technological and regulatory demands.

Industry experts point out that pharmaceutical quality can no longer be treated merely as a manufacturing function or a checklist of standard operating procedures. It must become an organisation-wide responsibility, supported by leadership commitment, employee accountability, transparency and an unwavering focus on patient safety. Regulatory agencies across international markets are increasingly examining the effectiveness of quality management systems alongside the organisational behaviours that determine how consistently quality principles are implemented.

This shift makes the development of a sustainable quality culture essential for pharmaceutical companies seeking to maintain regulatory confidence and access to international markets. Employees at every level must understand their responsibility for product quality, data integrity and ethical conduct rather than viewing compliance as the exclusive responsibility of quality assurance departments.

According to industry leaders, management commitment is central to this transformation. Companies must create an environment in which employees can report deviations, identify potential risks and raise quality concerns without fear of reprisal. Such psychological safety can encourage early reporting, strengthen corrective and preventive action systems and prevent recurring manufacturing and compliance failures.

Parallel to the quality challenge, the pharmaceutical sector faces a widening workforce skill gap as manufacturing and research activities increasingly incorporate biologics, advanced therapeutics, digital technologies and data-driven processes. Conventional training programmes, often conducted periodically, may not adequately prepare employees for these emerging requirements.

Experts advocate shifting towards continuous and structured skill enhancement programmes that combine micro-learning, simulation-based training and practical exposure. Micro-learning can help employees acquire specialised knowledge in manageable modules, while simulation-based environments can provide opportunities to understand complex manufacturing processes, equipment operations and quality-related situations without disrupting actual production.

Academic partnerships and industry-led training initiatives can further bridge the gap between theoretical education and workplace requirements. Establishing dedicated pharmaceutical academies, developing skill passports to document individual competencies and integrating digital literacy into workforce development programmes could help companies systematically assess and upgrade employee capabilities.

Industry leaders believe that skill development should be treated as a strategic business investment rather than an administrative training requirement. Digital talent marketplaces and competency-based learning frameworks can also help organisations identify internal capabilities, address skill shortages and deploy employees according to changing operational requirements.

The convergence of quality culture and skill enhancement is therefore critical to India's pharmaceutical growth strategy. A workforce that understands quality principles and possesses the technical capabilities to implement them can improve manufacturing consistency, regulatory compliance and innovation readiness.

As the industry expands its presence in global markets, experts emphasise that sustainable competitiveness will depend on combining ethical organisational practices with continuous learning. This transformation can help Indian pharmaceutical companies strengthen regulatory trust, protect patient safety and progress from manufacturing-led growth towards innovation-driven global leadership.

Share This Story

Leave a Reply
Your name (required)   Your email (required)
 
Website (required)
CommenT
Enter Code (Required)

 

 

 
INGREDIENT MART

RECENT NEWS

TOPICS
The Food and Drug Administration (FDA), Maharashtra, has issued a public advisory urging citizens to report any misleadi ...

 

MAIN LINKS OUR SERVICES OTHER PRODUCTS ONLINE MEDIA  
 
About Us
Contact Us
News Archives
 

Product Finder
Features and Articles
News
 
Chronicle Pharmabiz
Food & Bevergae News
Ingredients South Asia
 
Media Information
Rate Card
Advertise
 
 
Copyright © 2023 Saffron Media Pvt Ltd. All Rights Reserved.
Best View in Chrome (103.0) or Firefox (90.0)